L-Carnitine in the treatment of mild or moderate hepatic encephalopathy

Digestive Diseases

Volumn 21, Issue 3, 2003, Pages 271-275

  Malaguarnera, Mariano ^a,b   Pistone, Giovanni ^a   Astuto, Marinella ^a   Dell'Arte, Simona ^a   Finocchiaro, Giovanna ^a   Lo Giudice, Emilia ^a   Pennisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Università di Catania ^*  (Italy)

Author keywords

Hepatic encephalopathy; L Carnitine treatment

Indexed keywords

AMMONIA; CARNITINE;

ABDOMINAL PAIN; ADULT; ALCOHOL LIVER CIRRHOSIS; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FEMALE; HEADACHE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPROTECTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STATISTICAL SIGNIFICANCE; UREA CYCLE;

AMMONIA; CARNITINE; DOUBLE-BLIND METHOD; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; MALE; MENTAL HEALTH; MIDDLE AGED; PLACEBOS; TREATMENT OUTCOME;

EID: 0142218869     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073347     Document Type: Article

References (20)

1. Basile AS, Jones EA: Ammonia and GABAergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997;25:103-105.
2. Lockwood AH, Yap EWH, Wong WH: Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991;11:337-341.
3. Tarter RE, Panzak G, Switala J, Lu S, Simkevitz H, Van Thiel D: Isokinetic muscle strength and its association with neuropsychological capacity in cirrhotic alcoholics. Alcohol Clin Exp Res 1997;21:191-196.
4. Haussinger D, Kircheis G, Fischer R, Schiess F, Von Dahl S: Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 2000;32:1035-1038.
5. Ullian EM, Sepperstein SK, Christopherson KS, Barres BA: Control of synapse number by glia. Science 2001;291:657-661.
6. Noremberg MD: Astrocyte-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996;16:245-253.
7. Conn HO, Leevy CM, Vlahovic ZR, et al: Comparison of lactulose and neomycin in the treatment of chronic portal systemic encephalopathy. Gastroenterology 1997;72:573-583.
8. Bremer J: The role of carnitine in cell metabolism; in De Simone C, Famularo G (eds): Carnitine Today. Heidelberg, Springer, 1997, pp 1-37.
9. O'Connor JE, Costell M, Grisolia S: Prevention of ammonia toxicity by L-carnitine: Metabolic changes in brain. Neurochem Res 1984;9:563-570.
10. Therrien G, Rose C, Butterworth J, Butterworth RF: Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portocaval shunted rat. Hepatology 1997;25:551-556.
11. Reitan RM, Woegson D: The Halstead-Reitan. Neuropsycological test battery: theory and clinical interpretation. Tucson, Neuropsychology Press, 1993.
12. De Fonseca-Wollheim F: Direkte Plasmaammoniakbestimmung ohne Enteiweissung. J Clin Chem Clin Biochem 1973;11:421-431.
13. Conn HO, Liebertahl MM: The Hepatic Coma Syndrome and Lactulose. Baltimore, Williams & Wilkins, 1979, pp 1-121.
14. Conn HO: Trail-making and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977;22:541-550.
15. Rikkers L, Jenko P, Rudman D, Freides D: Subclinical hepatic encephalopathy: Detection prevalence and relationship to nitrogen metabolism. Gastroenterology 1978;75:462-469.
16. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO, McClain CJ: Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-521.
17. Matsouka M, Igsu H, Kohriyama K, Inoue N: Suppression of neurotoxicity of ammonia by L-carnitine. Brain Res 1991;567:328-331.
18. Atterbury CE, Maddrey WC, Conn HO: Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. Dig Dis 1978;23:398-408.
19. Hearn TJ, Coleman AE, Lai JCK, Griffith OW, Cooper AJL: Effect of orally administered L-carnitine on blood ammonia and L-carnitine concentrations in portocaval-shunted rats. Hepatology 1989;10:822-828.
20. Therrien G, Giguere JF, Butterworth RF: Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathy. Metab Brain Dis 1991;6:231-238.